Still struggling with complex bioassays?

	Antibodies
	The latest antibodies news from News Medical

Join ACROBiosystems' free webinar to explore how TR-FRET streamlines drug screening and mechanism-of-action studies.

Two Sessions Available:

· US: 12 PM EDT
· EU & APAC: 8 AM GMT | 9 AM CET

Discover TR-FRET principles & advantages, real-world applications in drug screening, and mechanistic studies.

Join the webinar here

			Breakthrough technology enables faster and cheaper antibody analysis Antibodies are the critical targeting agents of the immune system and the crux of immune therapy and vaccine development, but studying them is slow, expensive and labor-intensive.

			Novel method accurately identifies therapeutic antibodies to treat infectious diseases Scientists at Scripps Research have developed a novel method that uses artificial intelligence (AI) and advanced imaging techniques to more accurately and efficiently identify therapeutic antibodies to treat infectious diseases.

	Repurposed diabetes drugs boost CAR T therapy effectiveness in bladder cancer Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the United States. Despite recent advances, the 5-year survival rate for metastatic UC remains around five to ten percent.

	Early B cell response prevents Oropouche virus from reaching the brain Research conducted on mice has identified that the rapid response of a specific type of defense cell is essential for controlling Oropouche virus infections and preventing serious neurological damage.

	Penn State researchers reveal new function of antibody-producing cells The body has an intricate system to defend against infections where each type of immune cell plays a distinct role. Now, a study led by researchers from the Penn State College of Medicine has uncovered a new function of the immune cells that are known for making antibodies.

	New Research Highlights a More Efficient CAR T Treatment This review article focuses on the transformative potential of in vivo CAR T cell treatment in overcoming the constraints of standard CAR T cell production.

	Claudin 18.2-specific antibodies for population screening and clinical diagnosis Explore how Claudin 18.2-specific antibodies are transforming population screening by enabling more effective detection of cancer biomarkers.

	AACR 2024 spotlight on antibody-drug conjugate advancements Discover the latest advancements in antibody-drug conjugates presented at AACR 2024, including novel targets and combination therapy breakthroughs.

How would you rate today's newsletter?

Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025